Latest Insider Transactions at Agile Therapeutics Inc (AGRX)
This section provides a real-time view of insider transactions for Agile Therapeutics Inc (AGRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AGILE THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AGILE THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2024
|
Geoffrey Gilmore Chief Administrative Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,256
-74.99%
|
$20,256
$1.52 P/Share
|
|
Aug 26
2024
|
Amy Welsh Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,500
-87.5%
|
$13,500
$1.52 P/Share
|
|
Aug 26
2024
|
Paul Korner Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,500
-87.5%
|
$13,500
$1.52 P/Share
|
|
Aug 26
2024
|
Robert G Conway Chief Supply Chain Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,529
-87.42%
|
$13,529
$1.52 P/Share
|
|
Aug 26
2024
|
Scott M Coiante Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,080
-87.35%
|
$20,080
$1.52 P/Share
|
|
Aug 26
2024
|
Sharon Barbari Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
973
-100.0%
|
$973
$1.52 P/Share
|
|
Aug 26
2024
|
Josephine Torrente Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
987
-50.66%
|
$987
$1.52 P/Share
|
|
Aug 26
2024
|
John W Hubbard Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
976
-100.0%
|
$976
$1.52 P/Share
|
|
Aug 26
2024
|
Seth H. Z. Fischer Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
976
-100.0%
|
$976
$1.52 P/Share
|
|
Aug 26
2024
|
Alfred Altomari Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,749
-79.45%
|
$47,749
$1.52 P/Share
|
|
Aug 26
2024
|
Sandra Carson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
973
-100.0%
|
$973
$1.52 P/Share
|
|
Oct 03
2023
|
Scott M Coiante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+49.9%
|
-
|
|
Jun 28
2023
|
Geoffrey Gilmore Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,216
+37.41%
|
-
|
|
Jun 28
2023
|
Robert G Conway Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+49.95%
|
-
|
|
Jun 28
2023
|
Alfred Altomari Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,463
+32.48%
|
-
|
|
Jun 28
2023
|
Paul Korner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 28
2023
|
Amy Welsh Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Jun 08
2023
|
John W Hubbard Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.93%
|
-
|
|
Jun 08
2023
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.93%
|
-
|
|
Jun 08
2023
|
Josephine Torrente Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.62%
|
-
|
|
Jun 08
2023
|
Sharon Barbari Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.98%
|
-
|
|
Jun 08
2023
|
Sandra Carson Director |
BUY
Grant, award, or other acquisition
|
Direct |
935
+48.98%
|
-
|
|
Aug 26
2022
|
Alfred Altomari Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+43.73%
|
$0
$0.45 P/Share
|
|
Jun 09
2022
|
Josephine Torrente Director |
BUY
Grant, award, or other acquisition
|
Direct |
670
+20.13%
|
-
|
|
Jun 09
2022
|
James Patrick Tursi Director |
BUY
Grant, award, or other acquisition
|
Direct |
670
+24.49%
|
-
|
|
Jun 09
2022
|
Ajit Shetty Director |
BUY
Grant, award, or other acquisition
|
Direct |
670
+23.02%
|
-
|
|
Jun 09
2022
|
John W Hubbard Director |
BUY
Grant, award, or other acquisition
|
Direct |
670
+24.49%
|
-
|
|
Jun 09
2022
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
670
+24.49%
|
-
|
|
Jun 09
2022
|
Sandra Carson Director |
BUY
Grant, award, or other acquisition
|
Direct |
670
+25.55%
|
-
|
|
Jun 09
2022
|
Sharon Barbari Director |
BUY
Grant, award, or other acquisition
|
Direct |
670
+25.55%
|
-
|
|
Oct 13
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,734,560
+20.94%
|
$0
$0.85 P/Share
|
|
Oct 13
2021
|
Alfred Altomari Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
58,824
+9.3%
|
-
|
|
Oct 13
2021
|
Dennis Reilly Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
58,824
+17.1%
|
-
|
|
Oct 07
2021
|
Josephine Torrente Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,593
+50.0%
|
-
|
|
Jul 29
2021
|
Alfred Altomari Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
26,200
+4.84%
|
$26,200
$1.26 P/Share
|
|
Jul 27
2021
|
Dennis Reilly Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+18.1%
|
$50,000
$1.08 P/Share
|
|
Jun 08
2021
|
Sandra Carson Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,510
+32.33%
|
-
|
|
Jun 08
2021
|
James Patrick Tursi Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,510
+30.5%
|
-
|
|
Jun 08
2021
|
Ajit Shetty Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,510
+28.06%
|
-
|
|
Jun 08
2021
|
Sharon Barbari Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,510
+32.33%
|
-
|
|
Jun 08
2021
|
John W Hubbard Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,510
+30.5%
|
-
|
|
Jun 08
2021
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,510
+30.5%
|
-
|
|
May 18
2021
|
Alfred Altomari Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+3.93%
|
$20,000
$1.61 P/Share
|
|
May 11
2021
|
Dennis Reilly Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+10.19%
|
$20,000
$1.35 P/Share
|
|
Mar 29
2021
|
Jason Butch Principal Accounting Officer |
BUY
Open market or private purchase
|
Direct |
1,358
+6.36%
|
$1,358
$1.99 P/Share
|
|
Mar 26
2021
|
Jason Butch Principal Accounting Officer |
BUY
Open market or private purchase
|
Direct |
8,642
+31.67%
|
$17,284
$2.01 P/Share
|
|
Mar 23
2021
|
Dennis Reilly Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+24.24%
|
$100,000
$2.05 P/Share
|
|
Mar 23
2021
|
Alfred Altomari Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
12,500
+2.6%
|
$25,000
$2.0 P/Share
|
|
Jan 27
2021
|
Robert G Conway Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,461
+37.8%
|
-
|
|
Nov 19
2020
|
Robert G Conway Chief Supply Chain Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,149
+15.34%
|
$4,149
$1.76 P/Share
|